- Completion of an abstract submission affirms that all listed authors have agreed to its submission for presentation at the AUA Annual Meeting and publication of the abstract in the Journal of Urology® supplement. Submission of an abstract constitutes the author's commitment to present the abstract as accepted. The author/presenter is responsible for any expenses associated with the abstract's preparation, submission, and presentation. Registration fee waivers and travel grants are not available for abstract presenters.
- The submitting author will be required to complete a non-exclusive license agreement, as the AUA may capture accepted abstract presentations and use them as deemed appropriate for educational purposes.
- Abstract submissions must be written in English. All accepted abstracts must be presented in English.
- All completed abstract submissions are peer-reviewed and graded individually based on scientific merit and originality.
- Abstracts not selected for the AUA Annual Meeting may be considered for presentation at an appropriate International Society meeting, held during the AUA Annual Meeting, and will appear only in the program of those sessions. If you do not want your abstract to be considered for presentation at an International Society meeting, please check the indicated box in the submission form.
- Required fields for each author: First name, last name, email address, affiliation, city, state (U.S. only), and country. The submitting author must provide a unique email address belonging to each author.
- Do not include credentials (i.e., MD, PhD) in the name field. Please maintain consistency in authors' names across multiple abstract submissions.
- Though not required, please include the AUA ID for each author who has one.
- One author must be designated as the presenting author. The presenting author cannot be an employee of or have a financial relationship with the commercial interest that controls the content of the study or presentation.
- An individual may not serve as the presenting author on more than 5 abstracts accepted for presentation at the Annual Meeting.
Select the most appropriate category for the abstract. The Program Committee has the authority to recategorize an abstract.
The title should clearly define the topic and contain no abbreviations. For professional consistency, titles must be in sentence case and not bolded, underlined, italicized, or written in all caps or lowercase letters.
The AUA will ensure abstract titles are properly formatted for the various publications including the Journal of Urology®.
The text is limited to 2,280 characters, not including spaces. This includes the body of the abstract, tables, and graphics. Each table and/or graphic counts as 225 characters.
The body must be informative and detailed. The following sections are required:
- Introduction and objectives
- Conclusions (Indicate the major new findings of the study)
The inclusion of specific outcomes data is necessary for all abstracts; this also applies to Trials in Progress, which must supply at least preliminary results to be eligible for consideration. The AUA will reject abstracts with no listed results or abstracts with a statement that reads, "Results will be discussed".
Standard abbreviations: The full term should be written out during its first use, followed by the abbreviation in parentheses. Thereafter, the standard abbreviation may be used.
Proprietary drug names: It is not permissible to use proprietary drug names. Generic names must be used whenever possible.
Source of Funding
Authors must fully describe all funding sources. This field is required for submission. If there is no support to note, please list "None".
Abstracts deemed purely for marketing purposes will not be accepted.
All authors must disclose any conflicts of interest. The submitting author is required to enter the disclosure information for all authors. Please make sure you are aware of the disclosures of all authors before beginning the abstract submission process. A form to assist with the collection of disclosures is provided on the abstract submission site.
AUA membership is not required for abstract submission.
All communications will be sent to the email address of the presenting author of record. The presenting author is responsible for communicating all notifications with their co-authors.
Abstracts are not eligible for submission if the abstract or complete manuscript upon which the abstract is based is published in a journal or electronic publication prior to presentation at the AUA Annual Meeting.
Duplicate submissions by the same authors and based on the same study population or data will be rejected.
Revisions can be made by logging into the submission site before the deadline. The submitting author must ensure that the abstract status is "successfully submitted" after any changes are made.
Authors must review the abstract to ensure there are no errors in spelling or grammar, incorrect table/figures, missing author names, etc. Revisions will not be accepted after the deadline.
The submitting author may return to the abstract submission site to delete their submission at any time before 11:59 p.m. ET on November 8. After this date, requests to withdraw an abstract must be sent to speakers@AUAnet.org. Please include the abstract number, title, and reason for withdrawal. All co-authors must be copied on the communication. Requests which do not include all authors will not be processed.
The AUA Program Committee will determine the format of the presentation (podium or poster) and the AUA will inform the presenting author of the format at the time of acceptance notification.
Technical questions and submission issues can be sent to AUA@mirasmart.com. You may also call the Mira Tech Support line at (866) 341-9590 between the hours of 8 a.m. and 5 p.m., Central Time (14:00 to 23:00 GMT), Monday through Friday.
Please note: Mira is the abstract vendor and can only assist with technical submission questions and issues.
All other questions related to the abstract submission process can be sent to speakers@AUAnet.org.